Skip to main content

Lucia Linquan Carrillo Negredo

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Lucia Linquan Carrillo Negredo

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Iñigo Royo Crespo

Iñigo Royo Crespo

Senior researcher
General Surgery
Read more
Pau Sarle Valles

Pau Sarle Valles

Predoctoral researcher
Neurodegenerative Diseases
Read more
Simone Arndt

Simone Arndt

Research technician
Neurodegenerative Diseases
Read more
Andreu Antolin Redondo

Andreu Antolin Redondo

Predoctoral researcher
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.